Located in San Juan, Puerto Rico, FDI Clinical Research is a clinical research center with state-of-the-art facilities that comprise medical treatment for multiple conditions, a 30-bed phase I unit, an in-house bioanalytical laboratory, multispecialty experienced personnel, and the latest in medical technology...Learn more about us
The Next Epidemic in Puerto Rico Diabetes in the Puerto Rican population is estimated in almost 20% with an additional 30% of pre-diabetics in the baby boomer population. Even children are more prevalent to diabetes than in the past 10 years. Furthermore, metabolic syndrome is becoming a common disease in younger and middle age population increasing the probability to develop nonalcoholic fatty liver disease. At FDI-Clinical Research, we have run multiple studies with NAFLD and NASH. The Hispanic population is eager to participate. Contact us to show you our capabilities.
Bladder Cancer • Myelodysplasia • Lung Cancer • GBM • Hepatoma • Prostate Cancer • Gastric-GE Junction Cancer • Colon Cancer • (among others)
Our specialists in hematology and oncology decide on the best treatment for their patients’ diagnoses and consider clinical research participation as an option to manage their patients.
We are in collaboration with the Hematology and Oncology Section of the University of Puerto Rico to conduct clinical trials in hospitalized patients.
FDI is a main member of the Alliance for Clinical Trials in Oncology, a national clinical trials network sponsored by the National Cancer Institute.
Since 2010, we have conducted multiple clinical trials in Breast, Prostate, Hepatoma, Head and Neck, Gastric, and other types of cancers. We have also participated in various Phase 1 studies. Our expert oncologists are regarded to be in the forefront of treatment and have become speakers to multiple pharmaceutical companies for the Hispanic population. Contact us to help you run your clinical trial more efficiently and faster. selected for their competence, dedication and interest in clinical research.
A dedicated research pharmacy with the necessary equipment to prepare, formulate or compound any type of investigational drug
Bioanalytical Laboratory (FBL) is a unit of FDI Clinical Research that specialize in qualitative and quantitative analysis of chemical and biological pharmaceutical compounds.
Our phase I unit has state-of-the-art monitoring technology that includes remote telemetry and sophisticated software designed to manage phase I trials.
FDI has over 18 years of continuous research experience. Our staff has published over 150 manuscripts in prestigious journals
FDI is recognized as a center for excellence in medical care and a premier site for research on Latino patients
FDI Clinical Research invested $7 million on our facilities and the best up-to-date equipment. We can conduct trials from normal volunteers to phase IV. FDI has strict security and confidentiality controls that guarantee that research and samples are reliable, protected and evaluable for sponsors.